Vireo Growth Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Vireo Growth has been growing earnings at an average annual rate of 6.1%, while the Pharmaceuticals industry saw earnings growing at 46% annually. Revenues have been growing at an average rate of 23.7% per year.

Anahtar bilgiler

6.1%

Kazanç büyüme oranı

20.4%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi23.1%
Gelir büyüme oranı23.7%
Özkaynak getirisin/a
Net Marj-17.5%
Sonraki Kazanç Güncellemesi13 Nov 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Vireo Growth Inc.'s (CSE:VREO) 29% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Oct 12
Vireo Growth Inc.'s (CSE:VREO) 29% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Vireo Growth Inc. (CSE:VREO) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Aug 10
Vireo Growth Inc. (CSE:VREO) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Market Might Still Lack Some Conviction On Goodness Growth Holdings, Inc. (CSE:GDNS) Even After 30% Share Price Boost

Jun 01
Market Might Still Lack Some Conviction On Goodness Growth Holdings, Inc. (CSE:GDNS) Even After 30% Share Price Boost

Goodness Growth Holdings, Inc. (CSE:GDNS) Stock Rockets 30% But Many Are Still Ignoring The Company

Apr 06
Goodness Growth Holdings, Inc. (CSE:GDNS) Stock Rockets 30% But Many Are Still Ignoring The Company

Investors Still Aren't Entirely Convinced By Goodness Growth Holdings, Inc.'s (CSE:GDNS) Revenues Despite 59% Price Jump

Feb 01
Investors Still Aren't Entirely Convinced By Goodness Growth Holdings, Inc.'s (CSE:GDNS) Revenues Despite 59% Price Jump

Goodness Growth Holdings (CSE:GDNS) Is Carrying A Fair Bit Of Debt

Dec 14
Goodness Growth Holdings (CSE:GDNS) Is Carrying A Fair Bit Of Debt

Health Check: How Prudently Does Goodness Growth Holdings (CSE:GDNS) Use Debt?

Jul 14
Health Check: How Prudently Does Goodness Growth Holdings (CSE:GDNS) Use Debt?

Is Vireo Health International (CSE:VREO) Weighed On By Its Debt Load?

Mar 19
Is Vireo Health International (CSE:VREO) Weighed On By Its Debt Load?

Did Business Growth Power Vireo Health International's (CSE:VREO) Share Price Gain of 127%?

Jan 25
Did Business Growth Power Vireo Health International's (CSE:VREO) Share Price Gain of 127%?

Gelir ve Gider Dağılımı

Vireo Growth nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

CNSX:VREO Gelir, gider ve kazançlar (USD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 2498-17280
31 Mar 2493-24310
31 Dec 2388-26320
30 Sep 2383-34330
30 Jun 2377-37360
31 Mar 2378-36350
31 Dec 2275-42370
30 Sep 2269-43390
30 Jun 2264-41390
31 Mar 2257-41390
31 Dec 2154-34390
30 Sep 2153-22360
30 Jun 2152-13340
31 Mar 2150-22400
31 Dec 2049-23390
30 Sep 2048-63440
30 Jun 2042-78450
31 Mar 2036-62350
31 Dec 1930-57280
30 Sep 1925-17200
30 Jun 1922-4150
31 Mar 1921-4120
31 Dec 1818-3120
30 Sep 1816-290
31 Dec 1711060
31 Dec 164640

Kaliteli Kazançlar: VREO is currently unprofitable.

Büyüyen Kar Marjı: VREO is currently unprofitable.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: VREO is unprofitable, but has reduced losses over the past 5 years at a rate of 6.1% per year.

Büyüme Hızlandırma: Unable to compare VREO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Kazançlar vs. Sektör: VREO is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-40.8%).


Özkaynak Getirisi

Yüksek ROE: VREO's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin